Paraquat Lawsuit Dismissals: Special Master Recommends Tossing 196 Pulaski Kherkher Cases
On November 10, 2026, Special Master Randi Ellis recommended dismissing 196 paraquat lawsuits, all filed by Houston's Pulaski Kherkher, because no Plaintiff Assessment Questionnaires were served. It is the largest single round of paraquat lawsuit dismissals proposed in MDL 3004.
Torts Desk··21 min read

A court-appointed special master has recommended throwing out 196 paraquat Parkinson's disease lawsuits, all filed by a single Houston firm, because the plaintiffs never served the questionnaire the court requires of every claimant. Special Master Randi Ellis made the recommendation on November 10, 2026 to Chief Judge Nancy J. Rosenstengel of the Southern District of Illinois, who had not ruled when the Madison-St. Clair Record reported it on November 16; if adopted on the usual terms, it would be the largest single batch of paraquat lawsuit dismissals in the multidistrict litigation's history, though likely without prejudice.
The recommendation matters beyond its headcount. All 196 cases belong to Pulaski Kherkher, PLLC, a Houston plaintiffs' firm that also accounted for most of the cases dismissed in two earlier questionnaire rounds. According to the report, 195 of the 196 were filed in 2025 or 2026, after Syngenta and Chevron had already reached a settlement framework with plaintiffs' leadership, and none of those 195 had a completed questionnaire on file despite notices from the defense. For an MDL that the court has spent three years trying to clear of unsupported claims, and that is now policing settlement opt-outs firm by firm, the recommendation is another signal that the court will not carry cases whose owners have not done the basic intake work.
Why are 196 paraquat lawsuits facing dismissal?
The 196 paraquat lawsuits are facing dismissal because the plaintiffs did not serve a Plaintiff Assessment Questionnaire (PAQ), a short court-mandated disclosure that every claimant in MDL No. 3004 must provide within 30 days of filing. Special Master Ellis concluded that the plaintiffs had failed to comply with the court's order and recommended that Judge Rosenstengel dismiss all 196 cases on that ground.
The failure described in the reports is total rather than technical. This is not a set of questionnaires served late, or served with a missing pharmacy record or an unsigned verification. As reported, none of the 195 recent cases on the list had a completed questionnaire, even after Syngenta and Chevron sent the plaintiffs' counsel notices of the deficiency. That distinction matters under the court's procedure, which gives plaintiffs opportunities to cure an incomplete submission but treats a wholesale failure to respond as a violation of a court order.
The recommendation is also not a ruling on the merits. Nothing in the report says that any of the 196 plaintiffs lacks Parkinson's disease or lacks paraquat exposure. The point is narrower and procedural: a plaintiff who will not tell the court and the defendants the basic facts of the claim, in the format the court ordered, cannot keep a case on a managed MDL docket. Whether the underlying claims are strong or weak is a question the questionnaire is designed to start answering, and the questionnaire was never served.
Which law firm filed the 196 paraquat cases?
The 196 paraquat cases were filed by Pulaski Kherkher, PLLC, of Houston, Texas, which represents every plaintiff on the special master's list. The firm is a high-volume mass tort practice with a long-standing paraquat inventory in the Southern District of Illinois.
The firm has appeared on earlier dismissal lists in the same litigation:
- The 47-case round. When Ellis recommended dismissing 47 plaintiffs who had not uploaded questionnaires, the Madison-St. Clair Record reported that Pulaski Kherkher represented 27 of them. Judge Rosenstengel later dismissed all 47 on October 6 of that year, finding that the defendants had sent second notices even though the court did not require them, and that one plaintiff had not offered a reason to excuse his delay.
- The 117-to-69 round. On March 20, 2025, Ellis recommended dismissing 117 cases for overdue questionnaires; the Record reported that a single Pulaski Kherkher lawyer represented 105 of the overdue plaintiffs. By the time the court acted, the list had been trimmed, and on June 16, 2025 Judge Rosenstengel dismissed 69 cases, 57 of them Pulaski Kherkher filings.
- The 196-case round. All 196 cases on the November 10, 2026 list are Pulaski Kherkher cases.
No public statement from Pulaski Kherkher on the recommendation had been reported by November 22, 2026, and the published coverage does not say whether the firm intends to object. The pattern, though, is clear from the court's own record: across three rounds, one firm has supplied a majority of the plaintiffs recommended for dismissal for questionnaire noncompliance.
Two cautions belong alongside that pattern. First, a firm's appearance on a dismissal list can reflect client-side problems as much as law-firm ones: claimants who stop responding, die, move, or decide not to pursue the claim after a lawyer files to protect a limitations deadline. Second, a firm with a larger inventory will tend to appear more often in any compliance sweep. Neither caution explains why 195 recently filed cases would all lack a questionnaire, which is presumably why the special master did not treat them as individual cure problems.
What is the paraquat Plaintiff Assessment Questionnaire?
The paraquat Plaintiff Assessment Questionnaire is a short, court-ordered disclosure form, about 13 pages according to reports, that every plaintiff in MDL No. 3004 must serve under Case Management Order No. 10 within 30 days of filing a complaint. It asks for the basic facts of the claim: the Parkinson's disease diagnosis, how, when and where the plaintiff says paraquat exposure occurred, and supporting identification of the product and the application.
The PAQ is the paraquat MDL's version of an early screening tool that many mass tort courts now use. It is lighter than a full Plaintiff Fact Sheet (PFS), which in this litigation is reserved for cases selected for discovery, but it does similar work at the front of the case:
| Feature | Plaintiff Assessment Questionnaire (PAQ) | Plaintiff Fact Sheet (PFS) |
|---|---|---|
| Who must serve it | Every MDL plaintiff | Plaintiffs selected for discovery or ordered to by the court |
| When | Within 30 days of filing (CMO 10) | On a schedule set by later orders (for example, 14 days for some opt-out plaintiffs in 2026) |
| Purpose | Early screening of diagnosis and exposure | Full case-specific discovery |
| Standard | "Substantially complete," per CMO 10 | Complete, verified, with authorizations |
| Consequence of failure | Notice, cure opportunity, then a recommendation of dismissal | Motion practice, sanctions, dismissal |
Judge Rosenstengel has required the questionnaire since 2021, and its purpose has sharpened as the litigation has aged. In a May 2023 order the court said it was concerned about cases on its docket presenting "implausible or far-fetched" theories of liability, and it has since layered further exposure-evidence requirements on top of the PAQ, including an order (CMO 21) requiring plaintiffs to pursue third-party records, such as pesticide applicator and agricultural agency documents, to substantiate exposure. Against that background, a questionnaire is the minimum: it is the document that tells the court a case exists in more than name.
It also functions as the MDL's de facto Census Registry. Because every plaintiff must serve one, the PAQ set is how the parties and the Special Master know who is on the docket, what they claim, and which cases are candidates for settlement, discovery or dismissal. A case with no PAQ is, in practical terms, invisible to that process.
How a special master's report and recommendation becomes a dismissal
A special master's report and recommendation does not dismiss anything by itself; it becomes a dismissal only if Judge Rosenstengel adopts it, after the affected plaintiffs have had an opportunity to object. That sequence, rather than the special master's report, is what decides the fate of the 196 cases.
Federal Rule of Civil Procedure 53 governs masters in federal court. A party may object to a master's report within the time the rule or the appointing order sets, and the district judge decides objections to findings of fact and conclusions of law de novo, meaning the judge looks at the question fresh rather than deferring to the master. In practice, the paraquat court has used a predictable workflow for questionnaire deficiencies:
- Defense notice. Syngenta and Chevron identify plaintiffs with missing or deficient questionnaires and notify plaintiffs' counsel, sometimes more than once.
- Special master review. Ellis compiles the list of plaintiffs who remain noncompliant after notice and files a report and recommendation.
- Objection window. Plaintiffs can object, cure, or show good cause. Some plaintiffs have argued, for example, that their lawyers made good-faith attempts to reach unresponsive clients.
- Judicial decision. The judge adopts, modifies, or rejects the recommendation, case by case if necessary.
The court has not simply rubber-stamped these reports. In 2024 Judge Rosenstengel partially overruled a report recommending dismissal of 137 cases with incomplete questionnaires, and the 117-case list in 2025 shrank to 69 dismissals by the time the court ruled, as plaintiffs cured or the list was revised. Where no one objects, however, adoption is quick: in a June 10, 2026 order, the court fully adopted a recommendation and dismissed 27 cases without prejudice for noncompliance with CMO 10, noting that the affected plaintiffs had filed no objections.
That history suggests two realistic outcomes for the 196. Plaintiffs who serve a substantially complete questionnaire before the court rules, or who show a credible reason for the failure, may drop off the list. Those who do neither are likely to be dismissed.
Paraquat lawsuit dismissals so far: the docket-cleanup record
Paraquat lawsuit dismissals in MDL No. 3004 have come in waves, driven by the questionnaire requirement, exposure-evidence orders and voluntary withdrawals by plaintiffs selected for deposition. One Madison-St. Clair Record report put the court's cumulative total at more than 1,000 dismissed plaintiffs, almost all without prejudice. The questionnaire rounds that can be verified from court orders and contemporaneous reporting are these:
| Round | Recommendation | Court action | Pulaski Kherkher share | Prejudice |
|---|---|---|---|---|
| 47-case round | Ellis, July 17 report | All 47 dismissed October 6; one plaintiff's delay found unexcused | 27 of 47 | Without prejudice |
| 137-case round | Ellis, May 2024 report | Partially overruled by the court in 2024 | Not reported | Without prejudice where adopted |
| 117-case round | Ellis, March 20, 2025 report | 69 dismissed June 16, 2025 | 57 of 69 (105 of 117 on the original list) | Without prejudice |
| 27-case round | Ellis report, 2026 | All 27 dismissed June 10, 2026; no objections | Not reported | Without prejudice |
| 196-case round | Ellis, November 10, 2026 report | Pending | 196 of 196 | To be decided |
Several features stand out. The new list is larger than any previous questionnaire round. It is the first in which every listed plaintiff belongs to one firm. And it arrives at a later stage of the litigation than the earlier rounds: those cleaned up a docket preparing for bellwether trials, while this one lands on a docket in which most claimants have already been offered settlement and the court is focused on who is left.
The record also shows that questionnaire enforcement is only one track. The court has separately ordered depositions of plaintiffs whose exposure allegations looked doubtful, and a stream of plaintiffs selected for deposition have dismissed their own claims rather than sit for one. Syngenta and Chevron have also pressed the court, under the exposure-evidence order, to compel about 590 plaintiffs to produce third-party exposure records or face dismissal with prejudice. Paraquat lawsuit dismissals are, in short, the court's main tool for converting a docket of filings into a docket of claims.
Will the paraquat cases be dismissed with or without prejudice?
The 196 paraquat cases are most likely to be dismissed without prejudice if the court adopts the recommendation, because every comparable questionnaire round in MDL No. 3004 has ended that way. The reports on the November 10 recommendation do not state which form Ellis proposed, so that point remains to be confirmed when the court rules.
The difference is significant:
- Without prejudice means the dismissal is not an adjudication on the merits. The plaintiff may file the claim again, and the paraquat court's earlier orders describe dismissed plaintiffs as able to file another action within the MDL.
- With prejudice would bar the claim permanently. Under Federal Rule of Civil Procedure 41(b), a dismissal for failure to comply with a court order operates as an adjudication on the merits unless the court says otherwise, which is why MDL judges usually specify "without prejudice" for first-time questionnaire failures and reserve prejudice for repeat or willful noncompliance.
The court has signaled that the gap between the two can close. Defense requests in the exposure-evidence fight sought dismissal with prejudice for plaintiffs who ignored the CMO 21 deadlines, and the court has repeatedly warned that it will not carry implausible claims indefinitely. Plaintiffs who are dismissed once without prejudice and then refile without serving a questionnaire would face a much harder argument the second time.
Can a dismissed paraquat plaintiff refile?
A paraquat plaintiff dismissed without prejudice can generally refile, but only if the claim is still timely under the applicable statute of limitations, and the refiled case will have to meet the questionnaire requirement from day one. "Without prejudice" removes the bar of the dismissal itself; it does not stop the limitations clock.
That is the practical trap in a without-prejudice dismissal. Paraquat claims are governed by the limitations law of each plaintiff's home state, typically two or three years for personal injury, usually measured under a Discovery Rule from when the plaintiff knew or should have known of the injury and its possible cause. Most of the 196 cases were filed in 2025 or 2026. A plaintiff who filed near the end of a limitations period to preserve the claim, and is then dismissed, may find that the period has run by the time a new complaint is filed. Some states have savings statutes that allow refiling within a fixed period after a non-merits dismissal; others do not, or exclude dismissals for failure to prosecute. Whether a given plaintiff can refile is therefore a state-law question that the dismissal order will not answer.
A refiled case also carries its history. Defendants routinely raise prior dismissals when arguing that a plaintiff has not been diligent, and the paraquat court has already shown that it tracks which firms and plaintiffs have needed multiple warnings.
How many paraquat lawsuits are pending in MDL 3004?
There were 6,635 paraquat lawsuits pending in MDL No. 3004 as of November 2, 2026, out of 8,529 filed since the MDL was created, according to the Judicial Panel on Multidistrict Litigation (JPML). The 196 recommended dismissals equal about 3 percent of the pending docket.
| Measure | Figure | Source |
|---|---|---|
| Pending actions, MDL No. 3004 | 6,635 | JPML report, November 2, 2026 |
| Total actions ever filed in the MDL | 8,529 | JPML report, November 2, 2026 |
| Change in pending actions, October to November 2026 | +33 | JPML reports, October 1 and November 2, 2026 |
| Cases on the November 10 dismissal list | 196 | Special master report, as reported |
| Share of pending docket | About 3 percent | Calculation |
| Cases on the list filed in 2025 or 2026 | 195 | As reported |
| Paraquat plaintiffs reported refusing settlement offers | More than 900 | Press reports, late September 2026 |
Two features of the numbers deserve attention. First, the docket is still growing: the pending count rose by 33 between the October and November reports, which means new paraquat cases continue to be filed even after the settlement framework. Second, the gap between filings and pending cases, nearly 1,900 actions, reflects dismissals, voluntary withdrawals and other terminations over five years, much of it from the cleanup described above. Thousands more paraquat cases are pending in state courts, primarily in the Philadelphia Court of Common Pleas, which runs its own mass tort program and is not bound by the MDL's questionnaire order.
Does the paraquat dismissal affect the Syngenta settlement?
The paraquat dismissal recommendation does not change the terms of the Syngenta and Chevron settlement, but it bears on who can take part in it, because a plaintiff whose case is dismissed is no longer an MDL claimant with a pending case to resolve. The settlement terms, including the matrix values, have not been made public, so the exact eligibility rules for dismissed or late-filed claimants cannot be confirmed from the public record.
The timing still matters. Syngenta, Chevron and plaintiffs' leadership announced a signed settlement agreement in April 2025, executed a Master Settlement Agreement later in 2025 for certain individual claims, and the court approved a Qualified Settlement Fund (QSF) in March 2026. Case Management Order No. 24, entered in April 2026, required the settlement administrators to report to Special Master Ellis, by firm, which claimants had qualified, opted out or failed to qualify. Since then the court has:
- sampled roughly 10 percent of the opt-out cases from the Smith Law Firm and DiCello Levitt for early discovery (June 2, 2026);
- applied the same procedure to Nachawati Law Group after 183 of 217 eligible clients refused offers (June 3, 2026);
- required opt-out plaintiffs to meet with the Special Master and confirm an informed decision (June 2026); and
- ordered R. Allen Smith to disclose who funds his cases after only 49 of his 750 clients joined the settlement (October 14, 2026).
Cases filed after the settlement program was created are, under the court's 2026 orders, treated together with opt-outs and non-qualifiers as non-settling plaintiffs who must engage with the Special Master. That means the 195 recent Pulaski Kherkher filings sit in the part of the docket the court is watching most closely. A plaintiff in that group who has not served even the entry-level questionnaire cannot be evaluated for settlement, cannot be selected for discovery in a meaningful way, and gives the court little reason to keep the case open.
For the defendants, the dismissals also clarify the denominator. Mass tort settlements commonly depend on participation thresholds measured against the eligible claimant population. Clearing out cases that were never substantiated makes the remaining population more accurate, whatever the confidential threshold mechanics in this deal may be.
Paraquat lawsuit dismissals and the causation problem
Behind every procedural order in the paraquat MDL sits a substantive weakness that both sides understand: the court has excluded the plaintiffs' only general causation expert. On April 17, 2024, Judge Rosenstengel excluded the opinions of Dr. Martin Wells under Federal Rule of Evidence 702 and entered summary judgment against the four plaintiffs in the first bellwether pool, leaving no admissible expert testimony linking paraquat exposure to Parkinson's disease in those cases.
The plaintiffs appealed to the Seventh Circuit (Nos. 24-1865 through 24-1868), which heard argument in February 2025. After the parties signed their settlement letter agreement on April 14, 2025, they jointly asked the appeals court to hold the appeal in abeyance, and as of the latest reports it remains unresolved. That leaves every non-settling plaintiff in a difficult position: unless the Seventh Circuit reverses, or a new General Causation expert survives a fresh Daubert Challenge, an opt-out plaintiff's case faces the same evidentiary gap that ended the first bellwethers.
That context explains why the court treats compliance orders seriously. The settlement is the main path to compensation for MDL plaintiffs, the litigation path is uncertain, and the court is trying to ensure that the claimants left on its docket are real, informed and represented by counsel who are actually working the cases. A firm that files hundreds of cases and then does not serve the entry-level disclosure invites the inference, fair or not, that the cases were filed to hold a place rather than to be prosecuted.
Why would a firm file paraquat cases and not serve questionnaires?
The public record does not explain why the 195 recent Pulaski Kherkher cases lack questionnaires, and the firm has not publicly addressed it. The explanations that recur across mass torts when a court finds a block of noncompliant filings fall into a handful of categories, and each has different consequences for the plaintiffs involved.
Limitations-driven filing. Firms often file a complaint to stop the statute of limitations before they have gathered records or even confirmed key facts with the client. If the firm then cannot obtain the information, or the client stops responding, the case sits on the docket without a questionnaire. This is the most benign explanation, and it is also the one that leaves clients most exposed if the case is dismissed and the limitations period has since run.
Intake through referral networks or marketing. High-volume mass tort inventories are frequently built through advertising campaigns and referral relationships, with the filing firm receiving case files from intake vendors or co-counsel. Where intake screening is thin, the filing firm may discover only after filing that a claimant cannot document exposure or a diagnosis, or cannot be reached. Courts have grown skeptical of this pattern because it shifts screening costs onto the defendants and the court.
Settlement-timing strategy. In a litigation where a settlement framework already exists, a firm might file late cases expecting that they will be resolved through a claims process rather than litigated. The paraquat court's 2026 orders cut against that expectation by treating post-settlement filings as non-settling cases that must be supported like any other.
Administrative breakdown. Sometimes the cause is simply capacity: a firm managing several mass torts at once may fall behind on case-specific deadlines in one of them. That explanation can support a cure period but rarely excuses a failure across nearly every recent case.
Whatever the reason, the questionnaire requirement is designed to surface it early. Paraquat claims depend on proof of exposure to a restricted-use herbicide, typically through agricultural work, pesticide application or proximity to treated fields, and on a diagnosis of Parkinson's disease. Those facts are within the plaintiff's own knowledge and records. A court that asks for them within 30 days of filing is asking for information a well-screened case should already have, which is why the special master treated a total absence of questionnaires as a basis for dismissal rather than for another extension.
What happens next in the paraquat MDL?
What happens next is that Judge Rosenstengel will rule on the November 10 recommendation after the objection period, most likely dismissing without prejudice any of the 196 cases that remain without a questionnaire, while the court continues its supervision of opt-out plaintiffs and the Seventh Circuit appeal remains on hold.
The near-term calendar, as far as the public record shows, looks like this:
| Track | Status as of November 22, 2026 | What to watch |
|---|---|---|
| 196-case recommendation | Filed November 10; no ruling reported | Objections, cures, and the court's order (with or without prejudice) |
| Smith Law Firm opt-outs | Funding disclosure and fortnightly conferences ordered October 14 | What the disclosure shows; whether more clients accept offers |
| Opt-out discovery samples | PFS and depositions under the June 2026 orders | Whether any opt-out case is set for trial |
| Exposure-evidence orders (CMO 21) | Defense pressing for compliance and dismissals | Further dismissal motions, possibly with prejudice |
| Seventh Circuit appeal of Wells exclusion | Held in abeyance since 2025 | Whether the stay lifts if opt-outs proceed to litigation |
| Philadelphia state-court cases | Proceeding separately | Trial scheduling outside the MDL |
| New MDL filings | Pending count up 33 from October to November | Whether new filings slow as compliance enforcement continues |
The court may also respond to the pattern itself rather than only to the 196 cases. MDL judges have a range of tools for repeat compliance problems, including requiring certification by counsel that each new complaint has been investigated, entering a Lone Pine Order that demands prima facie evidence of exposure and causation by a deadline, or shortening cure periods for firms with repeated deficiencies. None of those steps has been reported in the paraquat MDL in connection with the November 10 recommendation, but each has been used in other mass torts when a court concludes that filings are outpacing preparation.
What it means for plaintiffs' firms, claimants, defendants and funders
For plaintiffs' firms with large inventories, the recommendation is a reminder that intake volume creates obligations the court will enforce at scale. A case filed in an MDL with a questionnaire order is a case that must be worked within 30 days, not merely docketed. Firms that file to preserve limitations periods before they have client cooperation or records are taking a calculated risk: if the client goes silent, the firm faces a dismissal list, and the client may face a refiling problem if the limitations period has run. The paraquat record also shows that courts remember: the same firm's name on successive lists invites closer scrutiny of the next batch.
For individual claimants, the practical lesson is that responsiveness to counsel matters. Many questionnaire failures begin with a lawyer who cannot reach a client, collect medical records or confirm exposure details. Claimants whose cases appear on a dismissal list can ask their lawyers whether a questionnaire has been served and whether an objection or cure is planned, because the window to act closes when the court rules.
For defendants, the paraquat MDL demonstrates the value of a disciplined notice-and-cure process. Syngenta and Chevron's practice of sending deficiency notices, sometimes beyond what the court required, has made it easier for the special master to recommend dismissal and for the judge to adopt it. A clean record of notice is what turns a missing form into an enforceable order.
For litigation funders and portfolio lenders, a docket with hundreds of unsubstantiated filings is a valuation problem. Case counts that drive Third-Party Litigation Funding facilities or Contingency Fee economics are worth far less if a substantial share cannot survive the entry-level questionnaire. The October 14 funding disclosure order directed at another firm shows the same court is prepared to ask who has a financial stake in a plaintiffs' inventory; funders underwriting mass tort books will want to know whether the cases they finance are being worked, not just filed.
For other MDL courts and practitioners elsewhere, the paraquat approach is a template. Early screening questionnaires, a Special Master who tracks compliance, and periodic batch recommendations of dismissal without prejudice have become standard docket-management features in large Multidistrict Litigation (MDL) proceedings. The paraquat record shows both their strength, a steady removal of claims no one is prosecuting, and their limit: without-prejudice dismissals keep the door open, so the same problem can return unless the court escalates.
This analysis describes the public record and is not legal advice.
FAQ
Why are 196 paraquat lawsuits facing dismissal?
Because the plaintiffs did not serve the Plaintiff Assessment Questionnaire required by Case Management Order No. 10. Special Master Randi Ellis recommended on November 10, 2026 that Chief Judge Nancy Rosenstengel dismiss all 196 cases for failing to comply with that order.
Which law firm filed the 196 paraquat cases?
All 196 plaintiffs are represented by Pulaski Kherkher, PLLC, of Houston, Texas. The same firm accounted for 57 of the 69 cases dismissed on the same ground in June 2025 and 27 of the 47 dismissed in an earlier round.
Will the paraquat cases be dismissed with or without prejudice?
The court has not ruled. Every earlier questionnaire round in MDL No. 3004 ended in dismissals without prejudice, which allows refiling, so that is the most likely outcome for plaintiffs who do not cure before the court acts.
Can a dismissed paraquat plaintiff refile?
A plaintiff dismissed without prejudice can usually refile, but only if the claim is still within the applicable state statute of limitations or a savings statute applies, and the new case must include a timely questionnaire.
How many paraquat lawsuits are pending in MDL 3004?
As of November 2, 2026, there were 6,635 pending paraquat lawsuits in MDL No. 3004, out of 8,529 filed, according to the JPML. The 196 recommended dismissals equal about 3 percent of the pending docket.
Does the paraquat dismissal affect the Syngenta settlement?
It does not change the settlement's confidential terms, but dismissed plaintiffs no longer have a pending MDL case to resolve, and the recommendation trims the pool of non-settling plaintiffs the court is supervising.
Published for legal professionals. Analysis and summaries only — not legal advice, and no attorney-client relationship is created by use of this site.
Read next

Paraquat Litigation Funding Disclosure: MDL Judge Orders Smith Law Firm to Reveal Who Funds Its Cases
On October 14, 2026, Judge Nancy Rosenstengel ordered R. Allen Smith to disclose who funds his paraquat cases after only 49 of his 750 clients joined the Syngenta-Chevron settlement. The order ties litigation funding disclosure directly to settlement consent.
Torts Desk · 20 min

Paraquat Settlement Opt-Outs Top 900 as MDL 3004 Judge Weighs a Return to Bellwether Trials
More than 900 Parkinson's plaintiffs have rejected Syngenta and Chevron's paraquat settlement offers, with three firms reporting opt-out rates of 80 to 100 percent. Paraquat settlement opt-outs now decide whether MDL 3004 settles or goes back to trial.
Torts Desk · 19 min

MDL Statistics November 2026: Uber's Pending Count Falls 368 as Social Media MDL Adds 485
The JPML's MDL statistics for November 2026 list 164 dockets, with J&J talc still largest at 69,376 actions. Uber's sexual assault MDL lost 368 pending cases while filings kept coming, social media addiction jumped 485, and hair relaxer passed 12,700.
Torts Desk · 22 min